earnings
confidence high
sentiment positive
materiality 0.75
Globus Medical Q2 revenue surges 115.9% to $629.7M; GAAP net income down 45%
GLOBUS MEDICAL INC
2024-Q2 EPS reported
$0.18
revenue$1,236,357,000
- Net sales $629.7M, up 115.9% as-reported; GAAP net income $31.8M, down 45% YoY.
- GAAP diluted EPS $0.23; non-GAAP diluted EPS $0.75, up 20% vs $0.63 prior year.
- Non-GAAP adjusted EBITDA $190.4M (30.2% of sales); operating cash flow $54.3M, FCF $26.5M.
- Raised FY2024 revenue guidance to $2.47B-$2.49B; non-GAAP EPS $2.80-$2.90.
- Growth driven by NuVasive acquisition, spine product volume, enabling technology sales.